Sign Out
There is no clinical experience with overdoses of SPEVIGO.
The highest dose of SPEVIGO administered in clinical trials was 1200 mg. Adverse events observed in subjects receiving single or repeated doses up to 1200 mg were consistent with the known safety profile of SPEVIGO.
In the event of overdose, it is recommended that the patient be monitored for any signs or symptoms of adverse reactions and symptomatic treatment be instituted as appropriate.
Continue with Google